The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Aptuit Greenwich, CT www.aptuit.com (855) 506-6360 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development and dosage form production SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, lyophilized products, non-sterile, parenterals (large volume), parenterals (small volume), powders (non-sterile), powders (sterile), semisolids, solid dose, solutions & suspensions, sterile, and syringes (pre-filled). "As a leading global pharmaceutical services company delivering early- to mid-phase drug development solutions, Aptuit is honored to be recognized for quality across all dosage forms. By applying scientific excellence, outstanding service and a team of some of the foremost scientific profes- sionals in the industry, our aim is to help customers realize their goals as efficiently, expeditiously and economically as possible … always at the highest level of quality." — Chris Bland Ph. D., site director, Aptuit (Glasgow) Ltd. DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Baxter BioPharma Solutions Deerfield, IL www.baxterbiopharmasolutions.com (800) 4-Baxter [229837] Manufacturing locations: Bloomington, IN, Englewood, CO, Halle/Westfalen, Germany, Hayward, CA, and Round Lake, IL Contact: Donna Abear biopharmasolutions@baxter.com Research & Development – clinical (phase 2 and phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: ADCs (antibody-drug conjugates) Aseptic fill/finish, cartridges, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, powders (sterile), proteins, solutions & suspensions, sterile, sustained release, syringes (pre-filled), and vaccines. "Baxter's heritage is built on 80+ years of healthcare innovation, including a long list of "firsts", such as the first closed system IV containers. Combining scientific expertise, quality and regulatory systems, sustainability and a global manufacturing network, Baxter provides a firm foundation to support the BioPharma Solutions contract manufacturing business. From formulation and development to lifecycle management, we are able to offer key capabilities to align with our clients' commercialization objectives and our mutual goal of moving patient care forward." — Robert Felicelli, global franchise head, Baxter's BioPharma Solutions business 36 The CMO Leadership Awards 2012 Contact: Stuart Needleman Stuart.needleman@aptuit.com DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development and dosage form production SERVICES OFFERED: Aseptic fill/finish, generics, liquids, lyophilized products, medical devices, parenterals (small volume), peptides, proteins, solutions & suspensions, and sterile. Avrio Biopharmaceuticals, LLC Irvine, CA www.avriobiopharma.com (866) 98-AVRIO [28746] Manufacturing location: Irvine, CA Contact: Katee Fry katee.fry@avriobiopharma.com "Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is dedicated to delivering high quality, flexible, and on-time cGMP aseptic fill-finish and CMC development services to the pharmaceutical, biopharmaceutical, and medical device industries. We have a 25 year history of understanding the importance of exceeding client expectations and we are committed to continuously enhancing and streamlining our services to provide clients with scientific solutions in an efficient manner." — Dr. Assad J. Kazeminy, president, founder, and CEO Boehringer Ingelheim Ingelheim, Germany www.bioxcellence.com 49 6132-77-95614 DRUG TYPE: Biopharmaceuticals Manufacturing locations: Biberach, Germany (mammalian), Fremont, CA, U.S.A. (mammalian), and Vienna, Austria, (microbial) DRUG LIFE CYCLE STAGES: Contact: Dr. Julia Knebel Julia.Knebel@boehringer-ingelheim.com Research & Development – pre-clinical, clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, cartridges, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, proteins, sterile, sustained release, syringes (pre-filled), and vaccines. "We are a leading biopharma contract manufacturer with 35 years of experience and an outstanding track record of 19 products brought to market. As an independent family-owned company, we see the contract manufacturing business as strategic priority which we underline with our new marketing brand Boehringer Ingelheim BioXcellence™. Our "one- stop-shop" concept from DNA to fill & finish makes outsourcing easy and provides tailor-made service solutions according to our customer's needs. With our global key account management team we are close to our customers and continue to put our customers first." — Simon Sturge, corporate senior vice president biopharmaceutical DRUG LIFE CYCLE STAGES